DrugCite
Search

FARMORUBICIN

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Farmorubicin Adverse Events Reported to the FDA Over Time

How are Farmorubicin adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Farmorubicin, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Farmorubicin is flagged as the suspect drug causing the adverse event.

Most Common Farmorubicin Adverse Events Reported to the FDA

What are the most common Farmorubicin adverse events reported to the FDA?

Interstitial Lung Disease
62 (5.36%)
Febrile Neutropenia
25 (2.16%)
Neutropenia
24 (2.08%)
Pyrexia
20 (1.73%)
White Blood Cell Count Decreased
18 (1.56%)
Cardiac Failure
16 (1.38%)
Platelet Count Decreased
15 (1.3%)
Neutrophil Count Decreased
14 (1.21%)
Haemoglobin Decreased
13 (1.12%)
Vomiting
12 (1.04%)
Acute Myeloid Leukaemia
10 (.87%)
Show More Show More
Hepatic Failure
10 (.87%)
Hepatitis B
10 (.87%)
Renal Failure Acute
10 (.87%)
Septic Shock
10 (.87%)
Blood Pressure Decreased
9 (.78%)
Diarrhoea
9 (.78%)
Nausea
9 (.78%)
Pneumocystis Jiroveci Pneumonia
9 (.78%)
Respiratory Failure
9 (.78%)
Cardiomegaly
8 (.69%)
Ejection Fraction Decreased
8 (.69%)
Pulmonary Oedema
8 (.69%)
Thrombocytopenia
8 (.69%)
Blood Bilirubin Increased
7 (.61%)
Cellulitis
7 (.61%)
Dyspnoea
7 (.61%)
General Physical Health Deteriorati...
7 (.61%)
Hepatic Necrosis
7 (.61%)
Hyponatraemia
7 (.61%)
Infection
7 (.61%)
Myelodysplastic Syndrome
7 (.61%)
Stomatitis
7 (.61%)
Alanine Aminotransferase Increased
6 (.52%)
Aspartate Aminotransferase Increase...
6 (.52%)
Depressed Level Of Consciousness
6 (.52%)
Headache
6 (.52%)
Hepatic Function Abnormal
6 (.52%)
Hypokalaemia
6 (.52%)
Hypothyroidism
6 (.52%)
Leukopenia
6 (.52%)
Lung Disorder
6 (.52%)
Malaise
6 (.52%)
Pain
6 (.52%)
Treatment Related Secondary Maligna...
6 (.52%)
Agranulocytosis
5 (.43%)
Aortic Valve Incompetence
5 (.43%)
Asthenia
5 (.43%)
Blood Lactate Dehydrogenase Increas...
5 (.43%)
Blood Pressure Increased
5 (.43%)
Bone Marrow Failure
5 (.43%)
Cardiac Murmur
5 (.43%)
Cardiac Valve Disease
5 (.43%)
Cytolytic Hepatitis
5 (.43%)
Dehydration
5 (.43%)
Depression
5 (.43%)
Eczema
5 (.43%)
Febrile Bone Marrow Aplasia
5 (.43%)
Feeling Abnormal
5 (.43%)
Hepatitis
5 (.43%)
Hyperlipidaemia
5 (.43%)
Left Ventricular Hypertrophy
5 (.43%)
Neoplasm Malignant
5 (.43%)
Neuralgia
5 (.43%)
Neutropenic Colitis
5 (.43%)
Off Label Use
5 (.43%)
Panniculitis
5 (.43%)
Pleural Effusion
5 (.43%)
Pneumonia
5 (.43%)
Supraventricular Extrasystoles
5 (.43%)
Transaminases Increased
5 (.43%)
Ventricular Extrasystoles
5 (.43%)
Weight Decreased
5 (.43%)
Anaemia
4 (.35%)
Anaphylactic Shock
4 (.35%)
Anorexia
4 (.35%)
Bacterial Sepsis
4 (.35%)
Blood Alkaline Phosphatase Increase...
4 (.35%)
Chest Discomfort
4 (.35%)
Contralateral Breast Cancer
4 (.35%)
Cough
4 (.35%)
Death
4 (.35%)
Electrocardiogram Abnormal
4 (.35%)
Hypoaesthesia
4 (.35%)
Liver Abscess
4 (.35%)
Loss Of Consciousness
4 (.35%)
Oxygen Saturation Decreased
4 (.35%)
Pancytopenia
4 (.35%)
Paresis
4 (.35%)
Renal Failure
4 (.35%)
Respiratory Distress
4 (.35%)
Rhabdomyolysis
4 (.35%)
Tremor
4 (.35%)
Urinary Tract Infection
4 (.35%)
Ventricular Fibrillation
4 (.35%)
Acidosis
3 (.26%)
Aortic Dissection
3 (.26%)
Ascites
3 (.26%)
Bacteraemia
3 (.26%)
Blood Amylase Increased
3 (.26%)
Blood Creatine Phosphokinase Increa...
3 (.26%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Farmorubicin, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Farmorubicin is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Farmorubicin

What are the most common Farmorubicin adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Farmorubicin, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Farmorubicin is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Farmorubicin According to Those Reporting Adverse Events

Why are people taking Farmorubicin, according to those reporting adverse events to the FDA?

Breast Cancer
211
Hepatic Neoplasm Malignant
44
Breast Cancer Recurrent
16
Breast Cancer Female
15
Breast Cancer Metastatic
12
Metastases To Liver
10
Show More Show More
Bladder Cancer
10
Gastric Cancer
8
Uterine Cancer
8
Drug Use For Unknown Indication
7
Therapeutic Embolisation
6
Metastases To Bone
6
Postoperative Care
6
Hepatic Cancer Metastatic
6
Non-hodgkins Lymphoma
4
Breast Cancer Stage Ii
4
Bladder Cancer Recurrent
3
Hodgkins Disease
3
Ovarian Cancer
3
Chemotherapy
3
Adenocarcinoma Of The Cervix
3
Metastatic Gastric Cancer
3
Acute Lymphocytic Leukaemia
3
Acute Myeloid Leukaemia
2
Small Cell Lung Cancer Metastatic
2
Acute Promyelocytic Leukaemia
2
Hepatic Neoplasm Malignant Recurren...
2
Hepatic Neoplasm
2
B-cell Lymphoma
2
Malignant Breast Lump Removal
2
Product Used For Unknown Indication
2
Small Cell Lung Cancer Stage Unspec...
2
Preoperative Care
2
Lung Disorder
2
Prophylactic Chemotherapy
1
Lymphoma
1
Metastases To Lung
1
Bladder Neoplasm
1
Breast Cancer Stage I
1
Metastases To Skin
1
Breast Cancer In Situ
1
Ovarian Cancer Recurrent
1
Ill-defined Disorder
1

Farmorubicin Case Reports

What Farmorubicin safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Farmorubicin. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Farmorubicin.